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Abstract: Neuropathological changes associated with Alzheimer’s disease
(AD) precede symptom onset by more than a decade. Possession of an
Apolipoprotein-E (APOE) ε4 allele is the strongest genetic risk factor for late
onset AD. Cross-sectional studies of cognitively intact elders have noted
smaller hippocampal/medial temporal volumes in ε4 carriers (ε4+) compared
to ε4 non-carriers (ε4-). Few studies, however, have examined long-term,
longitudinal, anatomical brain changes comparing healthy ε4+ and ε4individuals. The current five-year study examined global and regional volumes
of cortical and subcortical grey and white matter and ventricular size in 42
ε4+ and 30 ε4- individuals. Cognitively intact participants, ages 65-85 at
study entry, underwent repeat anatomical MRI scans on three occasions:
baseline, 1.5, and 4.75 years. Results indicated no between group volumetric
differences at baseline. Over the follow-up interval, the ε4+ group
experienced a greater rate of volume loss in total grey matter, bilateral
hippocampi, right hippocampal subfields, bilateral lingual gyri,
parahippocampal gyrus, and right lateral orbitofrontal cortex compared to the
ε4- group. Greater loss in grey matter volumes in ε4+ participants were
accompanied by greater increases in lateral, third and fourth ventricular
volumes. Rate of change in white matter volumes did not differentiate the
groups. The current results indicate that longitudinal measurements of brain
atrophy can serve as a sensitive biomarker for identifying neuropathological
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changes in persons at genetic risk for AD and potentially, for assessing the
efficacy of treatments designed to slow or prevent disease progression during
the preclinical stage of AD.
Keywords: Longitudinal Studies, MRI Scans, Alzheimer Disease, ApoE4

Introduction
The neuropathological changes associated with Alzheimer’s
disease (AD) may occur decades prior to the onset of clinical
symptoms.1 Identification of individuals in the preclinical stage of AD is
essential to developing successful interventions designed to prevent or
slow down the neuropathological processes leading to cognitive decline
and dementia. In addition to advancing age and a family history of
dementia,2 the ε4 allele of the Apolipoprotein-E (APOE) gene is a wellrecognized AD risk factor.3 Possession of the ε4 allele is associated
with a greater rate of hippocampal and medial temporal lobe atrophy
in patients diagnosed with Mild Cognitive Impairment (MCI) and AD.4,5
Conceivably, a greater rate of hippocampal and medial temporal lobe
atrophy could also be used to identify persons during the preclinical
stage of AD. One approach would involve the longitudinal study of
brain atrophy comparing cognitively intact elders possessing one or
both ε4 alleles with similarly aged non-carriers.
Longitudinal studies of brain atrophy comparing ε4 carriers and
non-carriers show mixed results (see Table 1). Most of these studies
focus on the hippocampus, due to its known relationship with early AD
pathogenesis.6 Some longitudinal studies have demonstrated that
cognitively intact elders possessing the ε4 allele experience greater
hippocampal atrophy over time compared to non-carriers,7-9 although
these results have not been demonstrated in other studies.10-12
Notably, most of these studies measured the rate of atrophy based on
two MRI assessments.
Only a few studies in Table 1 examined longitudinal changes in
brain regions outside the medial temporal lobes. A measure of total
brain volume demonstrated a greater rate of atrophy in ε4 carriers
than non-carriers.8 In one study, total grey matter volume atrophied
at a faster rate in ε4 homozygotes relative to ε4 heterozygotes and
non-carriers.13 Healthy ε4 carriers also experienced a greater rate of
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volume loss in the temporal lobes compared to non-carriers.14 No
study has yet reported comprehensive rates of change in global and
regional volumes comprising the entire brain.
The current study, therefore, evaluated the influence of the ε4
allele on brain volume changes in cognitively intact elders who
underwent repeat cognitive testing and anatomical MRI at study entry
and after 1.5 and 4.75 years. The three scan sessions enable a more
precise examination of the slope of volume change over time. The MRI
volumetric analysis, based on Freesurfer software, enabled a
comprehensive examination of global and regional grey and white
matter volumes and ventricular size, as well as specific examination of
the hippocampus and hippocampal subfields. We employed a
longitudinal linear mixed-effects (LME) analysis that permitted
modeling of the precise time intervals between assessments as well as
allowance for missing observations. We predicted that ε4 carriers
would exhibit greater atrophy than non-carriers in the hippocampus
and other cortical regions that are particularly vulnerable to AD
pathogenesis, such as the medial temporal4 and frontal regions.15

Materials and Methods
Participants
The recruitment strategy for this study, described in detail in
Seidenberg, et al.,16 involved over-sampling persons at genetic risk for
AD based on the presence of an APOE ε4 allele. Briefly, healthy older
adults between the ages of 65 and 85 were recruited from newspaper
advertisements. Screening via telephone of 459 individuals was
conducted for willingness to participate and to exclude participants
based on: MRI scanning criteria (e.g., weight inappropriate for height,
ferrous objects within the body, history of claustrophobia); non-right
handedness; depression [Geriatric Depression Scale (GDS)17 score >
20]; impaired activities of daily living [Lawton Instrumental Activities
of Daily Living (IADL)18 scale < 5]; current use of psychoactive
medications; and history of major neurological, medical, or psychiatric
(DSM-IV Axis-I criteria) diseases or disorders. All procedures were
approved by the Institutional Review Board of the Medical College of
Wisconsin, which had oversight of this study. Written informed consent
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was obtained from all participants and they received financial
compensation for their participation.
Of those meeting eligibility criteria, 109 agreed to undergo APOE
genotype testing from blood samples, a neuropsychological evaluation,
and an MRI scanning session. APOE genotype was determined using a
polymerase chain reaction method. DNA was isolated with Gentra
Systems Autopure LS for Large Sample Nucleic Acid Purification.19 We
excluded 31 ε4- participants who had a family history (FH) of AD to
isolate APOE as the primary AD genetic risk factor. FH was defined as
a reported first degree relative with a history of gradual decline in
memory and other cognitive domains, and confusion. Of the remaining
78 participants, only those with a minimum of two technically
adequate MRI scans were included in the final sample. Six participants
were excluded because they had only baseline data: withdrawal from
study (3), scan failure/refusal (2), and lost to followup (1).
The final sample consisted of 72 participants divided into two
groups: 1) the APOE ε4 positive group (ε4+; n=42), who were carriers
of one or both ε4 alleles (ε2/ε4: 1; ε3/ε4: 39; ε4/ε4: 2); and 2) the ε4
negative group (ε4-; n=30), (ε2/ε3: 2; ε3/ε3: 28). Table 2 shows the
baseline characteristics of the ε4+ and ε4- groups. No significant
group differences were observed for age or sex. A non-significant
trend was observed for education, with a mean 1.3 years of greater
attainment observed in the ε4+ than ε4- group; as a result, all
subsequent analyses employed education as a covariate. Two-thirds of
the ε4+ group had a FH of AD, whereas none of the ε4- group had a
FH. None of the participants had clinical levels of depression (GDS) or
problems with activities of daily living.
Mean follow-up intervals for the ε4+ participants were 1.5 years
(SD = 0.1) and 4.7 years (SD = 0.4). For the ε4- participants, the
follow-up intervals were 1.5 years (SD = 0.2) and 5.0 years (SD =
0.5). No significant group differences were observed. Three
participants (all ε4+) had baseline and second follow-up scans, but no
first follow-up scan; 21 participants (12 ε4+; 9 ε4-) completed
baseline and first follow-up scans, but were unable to be scanned at
the second follow-up due to: health decline (6), deceased (5), lost
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to follow-up (3), refused scan (3), moved away (3), and no longer safe
to be scanned (1). No group differences were observed in attrition
rates at each of the two follow-up scan sessions.

Procedure
For each session, neuropsychological testing and MRI were
conducted on the same day. Participants were asked to refrain from
alcohol use for 24 h and caffeine use 12 h prior to testing. The
neuropsychological test battery consisted of the Mini Mental State
Examination (MMSE) [20], Mattis Dementia Rating Scale 2 (DRS-2),21
and Rey Auditory Verbal Learning Test (RAVLT).22

MRI Acquisition and Processing
High-resolution, three-dimensional spoiled gradient-recalled at
steady-state (SPGR) anatomic images were acquired on a General
Electric (Waukesha, WI) Signa Excite 3.0 Tesla short bore scanner
equipped with a quad split quadrature transmit/receive head coil (TE =
3.9 ms; TR = 9.5 ms; inversion recovery (IR) preparation time = 450
ms; flip angle = 12°; number of excitations (NEX) = 2; slice thickness
= 1.0 mm; FOV = 24 cm; resolution = 256 × 224). A scanner upgrade
took place near the end of the final retest period. Six ε4+ participants
and one ε4- had their third scan conducted on a GE MR750 3.0 Tesla
scanner (TE = 3.9 ms; TR = 9.6 ms; inversion recovery (IR)
preparation time = 450 ms; flip angle = 12°; number of excitations
(NEX)=1; slice thickness = 1.0 mm; FOV = 24 cm;
resolution=256×224). A between-scanner comparison showed no
systematic differences. Whole brain and regional volumes were derived
from T1- weighted SPGR images using the longitudinal stream in
Freesurfer v.5.1 software.23

Statistical analysis
All data were analyzed using R software, version 3.2.2. A
longitudinal LME analysis was used to model the effects of genetic risk
and time on anatomical volumes, with baseline age, education and
intracranial volume included as covariates. LME permits an unequal
number of within-subject observations, making this technique flexible
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in cases where missing data may occur. The level-one random effects
model was linear within-subject volume as a function of time at
baseline and was used to assess volume differences at baseline
between carrier groups. Time was flexibly expressed as fractional
number of years since baseline for each observation in each subject.
The level-two fixed effects model estimated group differences in
the slope of volume change with years post baseline as the measure of
time. The non-carrier (ε4-) group provided the base (i.e., reference)
model; differences in rate of atrophy of the carrier (ε4+) group were
modeled with respect to the ε4- group. Thus, a statistically significant
slope in the non-carrier group is reflected by a rate of change greater
than 0 (data column 3 in Tables 3-7). A statistically significant group
difference (carrier vs. non-carrier) in slope is shown in data column 4
of Tables 3-7. A statistically significant slope in the non-carrier group
(data column 3), but a non-significant slope difference between the
carrier and non-carrier groups (data column 4), indicates that the rate
of change in both groups is comparable (i.e., normal aging effect).
The level-two model included nuisance variables as covariates,
including baseline age, intracranial volume and education. Residuals
were visually inspected using quantile–quantile plots to confirm the
assumption of normality. Coefficients, standard errors, t-statistics
and associated p-values were tabulated for each region. False
discovery rate was applied to correct for multiple comparisons; this
correction was applied separately to different classes of data (e.g.,
white matter vs. grey matter volumes). Statistically significant
negative slopes in the ε4- group represent atrophy as a function of
time that is comparable in both carriers and non-carriers. Statistically
significant negative slopes in the ε4+ vs. ε4- groups represent greater
rates of atrophy in ε4 carriers. Thus, regions that show greater rates
of atrophy in ε4 carriers compared to non-carriers represent atrophy
specific to the ε4 allele.
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Results
Baseline Cognitive Functioning
No significant group differences were observed on the MMSE,
the total score and subscales of the DRS-2, or the RAVLT; these
measures were well within the normal ranges.

LME Analyses
A quadratic model was also considered, but comparison of the
Akaike Information Criterion (AIC) for each model indicated that the
linear model was preferred. Table 3 summarizes results of the LME
analyses applied to the total left and right hippocampal volumes and
parcellated hippocampal subfields. No significant group differences
were observed at baseline (intercept) between the ε4- and ε4+
groups. No differences over time (slope) were observed in the ε4group. In contrast, the ε4+ group showed significantly greater rates of
change than the ε4- group in the left and right hippocampi (see top
panel of Figure 1) and multiple right sided hippocampal subfields:
Cornu Ammonis (CA)2/3, CA4/DG, presubiculum, and subiculum
(changes in CA2/3 and CA4/DG are shown in the middle panel of
Figure 1).
Table 4 summarizes results of whole brain cortical grey matter
(GM), white matter (WM), and ventricular volumes. No baseline group
differences were observed. Over time, both groups showed
significantly decreased volume in the right and left cortical WM and
increased volume within the right and left lateral, inferior lateral, third,
and fourth ventricles. The ε4+ group showed statistically greater rates
of atrophy in bilateral cortical GM and greater increases in volume of
the lateral, inferior lateral, and third ventricles compared to the ε4group. Longitudinal changes in the left and right lateral ventricles are
shown in the bottom panel of Figure 1.
Tables 5 and 6 summarize right and left cortical GM volumes,
respectively. No baseline group differences were observed. Decreased
volume of the right transverse temporal cortex and the left middle
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temporal, pars orbitalis, and superior temporal gyrus were observed in
the ε4- group over time. The ε4- group also showed increased volume
in left lingual gyrus over time. Compared to the ε4- group, the ε4+
group had a greater rate of atrophy within the lingual and
parahippocampal gyri (PHG) and right lateral orbitofrontal cortex
(OFC).
Tables 7 and 8 summarize right and left cortical WM volumes,
respectively. No significant group differences were observed at
baseline. The ε4- group experienced reduced volumes over time in 19
bilateral WM regions, six unique regions within the right hemisphere,
and 1 within the left hemisphere. Notably, the rate of decline in WM
regions did not differ between the ε4+ and ε4- groups.
Table 9 summarizes results of subcortical volumetric analyses.
No significant between group differences were observed at baseline.
Over time, the ε4- group had reduced volumes in the right and left
putamen, left accumbens, and left amygdala. No differences were
observed in the rate of change in volume over time between the ε4+
and ε4- groups.

Discussion
Our cognitively intact and healthy ε4 carriers and non-carriers,
who were enrolled between the ages of 65 and 85, did not
demonstrate any brain volumetric differences at study entry. Over the
course of the five-year follow-up interval, the rate of brain atrophy
was significantly greater in the carriers than in the non-carriers.
Consistent with prior investigations (see Table 1), we observed greater
shrinkage of the hippocampi in carriers than non-carriers. When
examining hippocampal subfields, we observed shrinkage primarily of
the CA2,3, CA4-DG, presubiculum and subiculum regions in the right
hemisphere. The greater atrophy seen in carriers relative to noncarriers is not confined to the hippocampus, but extends to the lingual
and parahippocampal regions, as well as the lateral orbitofrontal
cortex. Carriers also experienced global atrophic changes over time,
with greater reductions in total cortical GM and increases in the lateral
and third ventricles, compared to non-carriers. Finally, while
longitudinal reductions in total and regional WM volumes were
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prominent as part of the aging process, no differences in the rate of
WM atrophy were observed between carriers and non-carriers.
These findings suggest that possession of the APOE ε4 allele is
associated with more accelerated brain atrophy rates in healthy elders,
suggesting that some of the carriers may be experiencing the effects
of underlying AD-related neuropathology. Although we do not have
independent confirmation that the greater rates of atrophy in our
carriers are linked to AD neuropathology (i.e., evidence of amyloid-β
or tau from CSF or PET scans), we9 have previously reported that a
significantly higher percentage of our carrier group converted to a
diagnosis of MCI at the five year follow-up examination compared to
our non-carrier group. In the current sample, which overlaps but is not
identical to our previously published study,9 12 of 72 participants
(16.7%) met MCI criteria within the 5- year study period. Of these
participants, 10 were carriers and two were non-carriers. Thus, 10 of
42 (23.8%) carriers, but only 2 of 30 (6.7%) non-carriers, converted
to MCI. Given this association and the relatively small overall number
of MCI converters, it is not possible to examine the separate influence
of MCI conversion and carrier status on regional brain atrophy rates.
The precise mechanisms that link AD pathogenesis with the
APOE ε4 allele are not well understood. The APOE gene is related to
cholesterol metabolism and axonal repair after injury. The APOE ε4
allele negatively influences synaptic functioning and dendritic
branching.24 Other studies have suggested that ε4 confers a greater
risk to developing AD through inhibiting amyloid-β (Aβ) clearance.25,26
Aβ detected in healthy elders has been associated with neural
degeneration27 and specifically with hippocampal atrophy.28 The
current working hypothesis suggests that abnormal processing of Aβ
peptides and associated formation of Aβ plaques precede
neurodegenerative changes (i.e., atrophy) and cognitive dysfunction.1
Our results confirm previous research indicating that the most
profound and earliest AD-related atrophic changes are observed within
the hippocampal region. Hippocampal volume loss tracks AD disease
progression, with MCI patients showing greater hippocampal atrophy
compared to healthy elders and AD patients showing more pronounced
hippocampal atrophy than MCI patients.29 Our study extended
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previous investigations by examining volumetric rates of change in
hippocampal subfields. Our carriers demonstrated greater rates of
atrophy in CA2/3, CA4/dentate gyrus, presubiculum, and subiculum
layers (right hemisphere), whereas the CA1, fimbria, and hippocampal
fissure were not affected. Interestingly, although both the right and
left total hippocampal volumes showed greater rates of atrophy in
carriers compared to noncarriers, and both right and left hippocampal
subfields showed greater atrophy in the carriers than non-carriers,
only group differences in the right hippocampal subfields survived FDR
correction. This outcome may reflect statistical factors, such as sample
size and measurement variability, rather than true asymmetric rates of
atrophy within the subfields. Cross-sectional studies have
demonstrated smaller CA3 and dentate gyri30 and subiculum4 in
healthy elders with the ε4 allele. Furthermore, CA1 and subicular
atrophy has been shown to predict conversion from normal aging to
amnestic MCI over 6 years in a study that did not consider APOE
genotype.31
Our study found a greater rate of ventricular dilatation in
carriers relative to noncarriers. This increased rate of enlargement
occurred primarily within the lateral and third ventricles, with the
fourth ventricle being spared. Although we did not observe baseline
differences in ventricular volumes between carriers and non-carriers, a
cross sectional study reported greater ventricular volumes in healthy
older ε4 carriers relative to age matched non-carriers.32 Greater
longitudinal rates of change in lateral ventricular size are common in
AD, with rates of change in MCI and AD patients significantly greater
than in healthy elders.33 CSF measures of Aβ have been associated
with greater ventricular enlargement over time in healthy elders,
especially in ε4 carriers.34
Only one prior study13 has examined total GM atrophy in a 3.6year longitudinal study of elderly ε4 carriers. They observed a greater
total cortical GM atrophy rate in ε4 homozygotes than in ε4
heterozygotes and non-carriers using voxel based morphology (VBM).
In contrast to our study in which 95% of the carriers were
heterozygotes, no differences in GM atrophy rates were observed
between heterozygotes and non-carriers. These conflicting findings
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may be related to possible methodological differences between VBM
and Freesurfer in calculating bran volumes.
Carriers exhibited greater atrophy in bilateral lingual and
parahippocampal gyri and in right lateral orbitofrontal cortex. The
lingual and parahippocampal gyri appear to be particularly vulnerable
to AD-related neuropathology. Specifically, reduced cerebral metabolic
rates have been reported in these regions for ε4 carriers vs. noncarriers,35 and atrophy in these regions predicts conversion from MCI
to AD.36 Similarly, orbitofrontal cortex volume has been shown to
distinguish healthy elders from those with MCI and AD.37 Better lateral
orbitofrontal cortex perfusion has been shown to predict better
neuropsychological response to cholinesterase inhibitors in elders with
AD.38 Thus, the current study reinforces the early vulnerability and
predictive power of longitudinal volumetric study of non-hippocampal
regions in healthy elders who possess an ε4 allele.
Widespread WM atrophy occurred in both carriers and noncarriers over the course of the five-year follow-up interval. GM atrophy
appears to show a linear negative correlation with age, whereas agerelated WM microstructure damage and atrophy appear to take place
in a nonlinear fashion that does not correlate with, and may precede,
GM atrophy.39,40 Furthermore, WM atrophy in healthy elders has been
associated with etiological factors that may be independent of ADrelated neuropathology, e.g., hypertension41,42 and depression.43,44
Alternatively, it is conceivable that WM volumetric measures may be
less sensitive to AD-related pathology than microstructural changes to
WM as observed with diffusion tensor imaging.45,46
The current study identified specific hippocampal subfields,
namely the CA2,3, CA4-DG, presubiculum and subiculum that appear
to be vulnerable to atrophy in older carriers. Most of the previously
published longitudinal studies (Table 1) were conducted at 1.5T.7,8,10-14
The superior signal to noise ratio associated with 3T47,48 is critical for
delineating hippocampal subfields.49
Most prior studies examined longitudinal changes based on two
examination periods. By scanning three times over the course of the
five-year interval, we were in a position to determine if the atrophic
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changes accelerate over time, as reflected by a significant quadratic
effect. Our analyses, however, observed no evidence of a quadratic
change, suggesting that the increases in atrophy were linear in nature.
The current study has its limitations. We were unable to assess
AD-related pathology directly by examining CSF or PET markers of Aβ
or tau pathology. It might also have been useful to examine
inflammatory markers, such as Interleukin-6 (IL6), which can be
associated with plaque formation.50 Our analysis of hippocampal
subfields used the automatic FreeSurfer parcellation method, which
has been criticized by some for accuracy limitations.51 Finally, future
studies will require replication with a larger and more varied sex and
ethnicity distribution.
The current study sheds light on the importance of longitudinal
measurements of total and regional brain volumes for assessing ADrelated neuropathology in genetically atrisk healthy elders. The
success of future prevention studies hinges on the identification of
biomarkers that are sensitive to AD-related neuropathology during the
preclinical stage. Results of our study indicate that volumetric MRI
may be a candidate biomarker in future prevention studies involving
APOE ε4 carriers.
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Figure Legend:
Figure 1. Longitudinal volumetric change in the left and right total hippocampi (top),
right CA2,3 and CA4,DG hippocampal subfields (middle), and left and right lateral
ventricles (bottom) for the APOE e4+ (blue) and e4- (green) groups. The x axis plots
time in study, indexed in years; y axis indicates brain volume as a percent of
intracranial volume. Error bars = s.e.m.

Jouranl of Alzheimer’s Disease, Vol 55, No. 4 (2017): pg. 1363-1377. DOI. This article is © IOS Press] and permission has
been granted for this version to appear in e-Publications@Marquette. IOS Press] does not grant permission for this article
to be further copied/distributed or hosted elsewhere without the express permission from IOS Press.

19

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

Table 1: Longitudinal changes in hippocampal and non-hippocampal volume
in APOE ε4+ and ε4- elders who were cognitively intact and healthy at study
entry.

Notes: MRI was reported at 1.5T in all studies except Moffat et al. (2000), which was
unspecified and Rao et al. (2015) reported 3T; ^ = bilateral measurement; 3C=Three
City Study (France); AD=Alzheimer's disease; ADNI=Alzheimer's Disease
Neuroimaging Initiative; Aviation=Stanford/VA Aviation Study; BLSA=Baltimore
Longitudinal Study of Aging; ε4+=presence of an ε4 allele; ε4-=ε4 non-carrier; ε4*=non-ε4 carrier with presence of an ε2 allele; GM=grey matter; HC=hippocampus;
MT= Manual tracing; MTL=medial temporal lobes; NR= not reported for this group or
comparison; TC=temporal cortex.
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Table 2: Baseline characteristics of ε4+ and ε4- groups

Notes: ε4+ = ε4 allele carrier; ε4- = ε4 allele non-carrier; ADL = Activities of Daily
Living; GDS = Geriatric Depression Scale; MMSE = Mini Mental State Examination;
DRS = Dementia Rating Scale; RAVLT = Rey Auditory Verbal Learning Test
*p-values derived from Student's t-test, except for sex (Fisher's exact test)
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Table 3: Coefficients (±SEM) from linear mixed effects of total hippocampal
volumes and parcellated hippocampal subfields

Notes: All values in mL; ε4+ = ε4 allele carrier; ε4- = ε4 allele non-carrier; CA =
cornu ammonis; DG = dentate gyrus; Bolded values are statistically significant after
controlling for multiple comparisons using false discovery rate
a
Predicted mean intercept (baseline) of each region. Standard errors of coefficients
are in parentheses.
b Predicted mean intercept (baseline) of each structure by presence of ε4. Standard
errors of coefficients are in parentheses.
c Predicted average yearly rate of change (slope). Standard errors of coefficients are in
parentheses.
d Predicted average yearly rate of change (slope) by presence of ε4. Standard errors of
coefficients are in parentheses.
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Table 4: Coefficients (±SEM) from linear mixed effects of global cortical grey
and white matter and ventricular volumes

Notes: all values in mL; ε4+ = ε4 allele carrier; ε4- = ε4 allele non-carrier; GM=gray
matter; WM=white matter; Bolded values are statistically significant after controlling
for multiple comparisons using false discovery rate
a Predicted mean intercept (baseline) of each region. Standard errors of coefficients
are in parentheses.
b Predicted mean intercept (baseline) of each structure by presence of ε4. Standard
errors of coefficients are in parentheses.
c Predicted average yearly rate of change (slope). Standard errors of coefficients are in
parentheses.
d Predicted average yearly rate of change (slope) by presence of ε4. Standard errors of
coefficients are in parentheses.
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Table 5: Coefficients (±SEM) from linear mixed effects of Right Hemisphere
parcellated cortical grey matter regions

Notes: All values in mL; bankssts=banks of the superior temporal sulcus; ε4+ = ε4
allele carrier; ε4- = ε4 allele non-carrier; OFC=orbitofrontal cortex; Bolded values are
statistically significant after controlling for multiple comparisons using false discovery
rate
a Predicted mean intercept (baseline) of each region. Standard errors of coefficients
are in parentheses.
b Predicted mean intercept (baseline) of each structure by presence of ε4. Standard
errors of coefficients are in parentheses.
c Predicted average yearly rate of change (slope). Standard errors of coefficients are in
parentheses.
d Predicted average yearly rate of change (slope) by presence of ε4. Standard errors of
coefficients are in parentheses.
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Table 6: Coefficients (±SEM) from linear mixed effects of Left Hemisphere
parcellated cortical grey matter regions

Notes: All values in mL; bankssts=banks of the superior temporal sulcus; ε4+ = ε4
allele carrier; ε4- = ε4 allele non-carrier; OFC=orbitofrontal cortex; Bolded values are
statistically significant after controlling for multiple comparisons using false discovery
rate
a Predicted mean intercept (baseline) of each region. Standard errors of coefficients
are in parentheses.
b Predicted mean intercept (baseline) of each structure by presence of ε4. Standard
errors of coefficients are in parentheses.
c Predicted average yearly rate of change (slope). Standard errors of coefficients are in
parentheses.
d Predicted average yearly rate of change (slope) by presence of ε4. Standard errors of
coefficients are in parentheses.
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Table 7: Coefficients (±SEM) from linear mixed effects of Right Hemisphere
parcellated cortical white matter regions

Notes: All values in mL; bankssts=banks of the superior temporal sulcus; ε4+ = ε4
allele carrier; ε4- = ε4 allele non-carrier; OFC=orbitofrontal cortex; Bolded values are
statistically significant after controlling for multiple comparisons using false discovery
rate
a Predicted mean intercept (baseline) of each region. Standard errors of coefficients
are in parentheses.
b Predicted mean intercept (baseline) of each structure by presence of ε4. Standard
errors of coefficients are in parentheses.
c Predicted average yearly rate of change (slope). Standard errors of coefficients are in
parentheses.
d Predicted average yearly rate of change (slope) by presence of ε4. Standard errors of
coefficients are in parentheses.
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Table 8: Coefficients (±SEM) from linear mixed effects of Left Hemisphere
parcellated cortical white matter regions

Notes: bankssts= All values in mL; banks of the superior temporal sulcus; ε4+ = ε4
allele carrier; ε4- = ε4 allele non-carrier; OFC=orbitofrontal cortex; Bolded values are
statistically significant after controlling for multiple comparisons using false discovery
rate
a Predicted mean intercept (baseline) of each region. Standard errors of coefficients
are in parentheses.
b Predicted mean intercept (baseline) of each structure by presence of ε4. Standard
errors of coefficients are in parentheses.
c Predicted average yearly rate of change (slope). Standard errors of coefficients are in
parentheses.
d Predicted average yearly rate of change (slope) by presence of ε4. Standard errors of
coefficients are in parentheses.
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Table 9: Coefficients (±SEM) from linear mixed effects of parcellated
subcortical Grey Matter regions

Notes: All values in mL; ε4+ = ε4 allele carrier; ε4- = ε4 allele non-carrier; Bolded
values are statistically significant after controlling for multiple comparisons using false
discovery rate
a Predicted mean intercept (baseline) of each region. Standard errors of coefficients
are in parentheses.
b Predicted mean intercept (baseline) of each structure by presence of ε4. Standard
errors of coefficients are in parentheses.
c Predicted average yearly rate of change (slope). Standard errors of coefficients are in
parentheses.
d Predicted average yearly rate of change (slope) by presence of ε4. Standard errors of
coefficients are in parentheses.
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